Buchang Pharmaceutical Co., Ltd., Shandong Buchang Pharmaceutical Co., Ltd., is a joint venture between Taiwan, Hong Kong, Macao and China, engaged in the production and sales of R&D and Chinese patent medicines. The main products of Shandong Buchang Pharmaceutical Co., Ltd. are in the leading position in the field of cardiovascular and cerebrovascular drugs, and have established a strong competitive advantage in the fields of gynecology, urology and other drugs.
Shandong Buchang Pharmaceutical Co., Ltd. (referred to as Buchang Pharmaceutical) was established on 200 1 and completed the shareholding system reform on 20 12. 20 16 was approved by the IPO of the audit committee of China Securities Regulatory Commission in July, and successfully listed in 20118 10.
Based on the theory of treating brain and heart at the same time, Buchang Pharmaceutical has developed three exclusive patented varieties, namely Naoxintong Capsule, Wenxin Granule and Danhong Injection, covering common cardiovascular and cerebrovascular diseases such as stroke, arrhythmia, insufficient blood supply and ischemic infarction. As a leading enterprise of patent prescription drugs for traditional Chinese medicine, its main products are also highly competitive in gynecological medicine, diabetes, cancer and other fields. Gynecological medicine "Red Core Jeff Lotion" is three kinds of new traditional Chinese medicine, which is the exclusive variety of the company. The company has also achieved product coverage in the fields of pediatrics, anti-tumor, urinary digestion, bone and joint, respiratory system, etc., and has best-selling products such as Qianlie Shutong Capsule, Ganshuang, Kelu Oral Liquid and Xiasangju Granule.
At present, the company can produce capsules, granules, injections and other dosage forms. 2065438+September 2008, Buchang officially announced the transformation, from marketing-driven to product-driven and to technology-based companies; From Chinese patent medicine to biomedicine, chemical medicine, medical equipment, internet medicine and other industries; From localization to globalization in China, the strategic planning of biopharmaceuticals will be realized steadily.
In the future, a big health industry will be laid out, based on patented Chinese medicine, biopharmaceuticals and Internet medical care (mobile medical care, wearable medical care, e-commerce, etc.). ), health products, medical devices, hospitals, etc. Will actively explore. With the strength and rise of China, Buchang Pharmaceutical will further deepen its global layout, and strive to become a company with a market value of 100 billion through product merger and enterprise merger.
The growth of Buchang Pharmaceutical benefits from the reform of China's market economy system and medical and health system, and it is also inseparable from China's good investment environment. "China's Johnson & Johnson is a big step in the world" is the company's vision. The company will continue to make due contributions to the development of regional economy and medical industry, and repay investors and society with excellent performance.